Several evaluations confirmed the higher level of prolactin in patients with psoriasis [20–22]; also, they reported the therapeutic effects of bromocriptine (antiprolactin secretion) on different autoimmune diseases including psoriasis, rheumatoid arthritis, and Reiter's syndrome [19]. This evidence concerns the gene PRL and autoimmune disease.